NCT00317915View on ClinicalTrials.gov

Irbesartan in Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Type 2 DiabetesMicroalbuminuriaHypertension
Interventions
DRUG

Irbesartan treatment

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Sanofi-Synthelabo

INDUSTRY

lead

Steno Diabetes Center Copenhagen

OTHER

NCT00317915 - Irbesartan in Type 2 Diabetes | Biotech Hunter | Biotech Hunter